Letter to the Editor

Plasma 5-miRNA as Biomarkers for Identifying Prostate Cancer Patients

1. Zhi F, Shao N, Li B et al (2016). A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma. Sci Rep, 6:32067.
2. Brase JC, Wuttig D, Kuner R, Sültmann H (2010). Serum microRNAs as non-invasive biomarkers for cancer. Mol Can-cer, 9:306.
3. Hellwinkel OJ, Sellier C, Sylvester YM et al (2013). A cancer-indicative microRNA pattern in normal prostate tissue. Int J Mol Sci, 14(3):5239-49.
4. Xu B, Huang Y, Niu X, et al (2015). Hsa‐miR‐146a‐5p modulates androgen‐independent prostate cancer cells apop-tosis by targeting ROCK1. Prostate, 75(16):1896-903.
5. Zhang W, Mao YQ, Wang H et al (2015). MiR-124 suppresses cell motility and ad-hesion by targeting talin 1 in prostate cancer cells. Cancer Cell Int, 15:49.
6. Liu C, Chen Z, Hu X et al (2015). Mi-croRNA-185 downregulates androgen receptor expression in the LNCaP pros-tate carcinoma cell line. Mol Med Rep, 11(6):4625-32.
Files
IssueVol 48 No 9 (2019) QRcode
SectionLetter to the Editor
DOI https://doi.org/10.18502/ijph.v48i9.3038
Keywords
No keywords###

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
SAFFARI M, MODARRESSI MH, SHIRKOOHI R, HASSANI B, AFSHARPAD M, RAFIEI G, ABROODI G, YEKANINEJAD MS, ARFAEE J, AKRAMI SM. Plasma 5-miRNA as Biomarkers for Identifying Prostate Cancer Patients. Iran J Public Health. 2019;48(9):1743-1745.